Oncodetect On-demand Recording

View our latest presentation

Watch our Industry Expert Theater session from the 2026 ASCO® Annual Meeting: Advancing molecular residual disease (MRD) detection: analytics and clinical evidence supporting the Oncodetect® test, presented by our Chief Medical Officer Rick Baehner, MD, and Senior Principal Medical Affairs Director Jennifer Racz, MD, MBA.

View this recording to learn:

  • How the Oncodetect test works and its analytical and clinical performance
  • Next-generation MRD testing approach with whole-genome MAESTRO technology
  • Findings from the NSABP-59 study and PARTNER MRD sub-study, illustrating the evolving role of MRD testing in breast cancer management
Advancing Molecular Residual Disease Detection: Analytical and clinical evidence supporting the Oncodetect test.
Advancing Molecular Residual Disease Detection: Analytical and clinical evidence supporting the Oncodetect test.